LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
+8.99%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.97B
AUM Growth
+$1.97B
(+31%)
Cap. Flow
+$367M
Cap. Flow
% of AUM
18.65%
Top 10 Holdings %
Top 10 Hldgs %
16.48%
Holding
519
New
126
Increased
265
Reduced
66
Closed
19
Top Buys
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$26.2M |
| 2 |
Biogen
BIIB
|
$26.1M |
| 3 |
Ameriprise Financial
AMP
|
$25.1M |
| 4 |
InMode
INMD
|
$23.7M |
| 5 |
BioNTech
BNTX
|
$21M |
Top Sells
| 1 |
Moderna
MRNA
|
$29.5M |
| 2 |
Futu Holdings
FUTU
|
$23.2M |
| 3 |
Intellia Therapeutics
NTLA
|
$20.7M |
| 4 |
Charles Schwab
SCHW
|
$18M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
$10.5M |
Sector Composition
| 1 | Healthcare | 50.36% |
| 2 | Consumer Discretionary | 12.8% |
| 3 | Financials | 9.81% |
| 4 | Technology | 6.13% |
| 5 | Industrials | 3.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
GoodRx Holdings
GDRX
$1.48B
| $40.7M | 2.06% |
1,129,083
+364,304
| +48% | +$13.1M |
|
2
Exact Sciences
EXAS
$9.05B
| $34.4M | 1.75% |
276,921
+62,311
| +29% | +$7.75M |
|
3
American Express
AXP
$228B
| $34.4M | 1.74% |
208,021
-24,598
| -11% | -$4.06M |
|
4
IQVIA
IQV
$31.4B
| $32.4M | 1.64% |
133,563
+11,875
| +10% | +$2.88M |
|
5
Thermo Fisher Scientific
TMO
$182B
| $31.9M | 1.62% |
63,220
-4,065
| -6% | -$2.05M |
|
6
Keysight
KEYS
$27.7B
| $31.6M | 1.6% |
204,655
+517
| +0.3% | +$79.8K |
|
7
Lowe's Companies
LOW
$145B
| $30.3M | 1.53% |
155,976
-25,399
| -14% | -$4.93M |
|
8
Tandem Diabetes Care
TNDM
$851M
| $30.1M | 1.53% |
309,447
+81,116
| +36% | +$7.9M |
|
9
UnitedHealth
UNH
$281B
| $29.2M | 1.48% |
72,873
+22,072
| +43% | +$8.84M |
|
10
Merck
MRK
$212B
| $29.1M | 1.48% |
374,559
+56,753
| +18% | +$4.41M |
|
11
Equity Lifestyle Properties
ELS
$11.6B
| $28.2M | 1.43% |
380,000
+110,000
| +41% | +$8.17M |
|
12
Labcorp
LH
$22.9B
| $27.9M | 1.41% |
100,967
+10,078
| +11% | +$2.78M |
|
13
Abbott
ABT
$229B
| $27.2M | 1.38% |
234,614
+37,194
| +19% | +$4.31M |
|
14
AbbVie
ABBV
$372B
| $27.2M | 1.38% |
241,139
+28,310
| +13% | +$3.19M |
|
15
Hologic
HOLX
$14.8B
| $27.1M | 1.38% |
406,358
+3,217
| +0.8% | +$215K |
|
|
LHCG
16
DELISTED
LHC Group LLC
LHCG
| $27M | 1.37% |
135,000
+25,000
| +23% | +$5.01M |
|
17
Service Corp International
SCI
$11B
| $26.8M | 1.36% |
500,000
| – | – |
|
|
18
Biogen
BIIB
$20.1B
| $26.7M | 1.35% |
77,129
+75,362
| +4,265% | +$26.1M |
|
19
Visa
V
$676B
| $26.6M | 1.35% |
113,583
-6,795
| -6% | -$1.59M |
|
20
Natera
NTRA
$23B
| $26.5M | 1.34% |
233,468
+70,190
| +43% | +$7.97M |
|
|
BHVN
21
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $26.2M | 1.33% |
+270,358
| New | +$26.2M |
|
22
Twist Bioscience
TWST
$1.57B
| $26.2M | 1.33% |
196,676
+89,273
| +83% | +$11.9M |
|
23
Pultegroup
PHM
$26B
| $26M | 1.32% |
476,499
-24,125
| -5% | -$1.32M |
|
24
NeoGenomics
NEO
$1.13B
| $25.6M | 1.3% |
566,461
+203,619
| +56% | +$9.2M |
|
|
25
Ameriprise Financial
AMP
$47.8B
| $25.4M | 1.29% |
102,159
+100,918
| +8,132% | +$25.1M |
|